Patients
Learn About Oligonucleotide Therapeutics
Cardiovascular, metabolic, renal, and liver diseases affect the lives of millions around the world.
Every patient facing these challenges inspires and guides us. Our development of new therapeutics, from the lab to the clinic, is driven by a single purpose: to make treatments more precise, effective, and accessible for all.
Our Focused Therapeutic Area
We focus on cardiovascular, metabolic, renal and liver diseases, as well as other therapeutic areas. These key therapeutic areas represent areas of significant global medical burden with limited treatment options and involve underlying pathogenic mechanisms that are aligned with the targeting capabilities of our technology platforms.
Learn About Our Products
Please check out the variety of drugs currently in development to learn how these drugs offer more possibilities for patient care.
